ASX - By Stock
|
IMC |
Re:
Banter and General Comments
|
|
awildana
|
26 |
8.3K |
1 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
26
|
8.3K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
awildana
|
164 |
45K |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
164
|
45K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
awildana
|
164 |
45K |
2 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
164
|
45K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
awildana
|
164 |
45K |
0 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
164
|
45K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
awildana
|
164 |
45K |
1 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
164
|
45K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
awildana
|
164 |
45K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Credit Given Where Due, However.
|
|
awildana
|
7 |
1.6K |
1 |
11/02/24 |
11/02/24 |
ASX - By Stock
|
7
|
1.6K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Credit Given Where Due, However.
|
|
awildana
|
7 |
1.6K |
0 |
11/02/24 |
11/02/24 |
ASX - By Stock
|
7
|
1.6K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Under the radar
|
|
awildana
|
37 |
9.7K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
37
|
9.7K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Under the radar
|
|
awildana
|
37 |
9.7K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
37
|
9.7K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Under the radar
|
|
awildana
|
37 |
9.7K |
1 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
37
|
9.7K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Under the radar
|
|
awildana
|
37 |
9.7K |
0 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
37
|
9.7K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Announces First Patients Enrolled In Campylobacter Challenge Clinical Study
|
|
awildana
|
7 |
2.3K |
0 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
7
|
2.3K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Announces First Patients Enrolled In Campylobacter Challenge Clinical Study
|
|
awildana
|
7 |
2.3K |
2 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
7
|
2.3K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Announces First Patients Enrolled In Campylobacter Challenge Clinical Study
|
|
awildana
|
7 |
2.3K |
0 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
7
|
2.3K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Announces First Patients Enrolled In Campylobacter Challenge Clinical Study
|
|
awildana
|
7 |
2.3K |
0 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
7
|
2.3K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Investor Webinar Presentation
|
|
awildana
|
5 |
1.9K |
3 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
5
|
1.9K
|
3
|
|
ASX - By Stock
|
IMC |
Beating bacteria
|
|
awildana
|
0 |
214 |
3 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
0
|
214
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO, Steven Lydeamore to present at AusBioInvest
|
|
awildana
|
9 |
2.3K |
1 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
9
|
2.3K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan Clinical Study Cohort 2 commences
|
|
awildana
|
10 |
2.9K |
0 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
10
|
2.9K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron achieves record quarterly Travelan sales
|
|
awildana
|
9 |
2.7K |
0 |
15/10/23 |
15/10/23 |
ASX - By Stock
|
9
|
2.7K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron achieves record monthly Travelan sales
|
|
awildana
|
33 |
7.5K |
0 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
33
|
7.5K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron present to Military Health System Research Symposium
|
|
awildana
|
13 |
4.2K |
0 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
13
|
4.2K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron present to Military Health System Research Symposium
|
|
awildana
|
13 |
4.2K |
2 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
13
|
4.2K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron Receives TGA GMP Clearance
|
|
awildana
|
9 |
2.6K |
0 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
9
|
2.6K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron Receives TGA GMP Clearance
|
|
awildana
|
9 |
2.6K |
0 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
9
|
2.6K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron Receives TGA GMP Clearance
|
|
awildana
|
9 |
2.6K |
0 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
9
|
2.6K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron enrols patients in Travelan clinical study
|
|
awildana
|
4 |
1.8K |
0 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
4
|
1.8K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron enrols patients in Travelan clinical study
|
|
awildana
|
4 |
1.8K |
1 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
4
|
1.8K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
The Assure GI Competiture
|
|
awildana
|
11 |
3.2K |
0 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
11
|
3.2K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
The Assure GI Competiture
|
|
awildana
|
11 |
3.2K |
0 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
11
|
3.2K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
The Assure GI Competiture
|
|
awildana
|
11 |
3.2K |
4 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
11
|
3.2K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
The Assure GI Competiture
|
|
awildana
|
11 |
3.2K |
0 |
16/07/23 |
16/07/23 |
ASX - By Stock
|
11
|
3.2K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
The Assure GI Competiture
|
|
awildana
|
11 |
3.2K |
1 |
16/07/23 |
16/07/23 |
ASX - By Stock
|
11
|
3.2K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
The Assure GI Competiture
|
|
awildana
|
11 |
3.2K |
0 |
15/07/23 |
15/07/23 |
ASX - By Stock
|
11
|
3.2K
|
0
|
|
ASX - By Stock
|
IMC |
The Assure GI Competiture
|
|
awildana
|
11 |
3.2K |
0 |
15/07/23 |
15/07/23 |
ASX - By Stock
|
11
|
3.2K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Juvia
|
|
awildana
|
1 |
836 |
2 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
1
|
836
|
2
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Announces Chairman Transition
|
|
awildana
|
14 |
3.5K |
3 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
14
|
3.5K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Announces Chairman Transition
|
|
awildana
|
14 |
3.5K |
2 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
14
|
3.5K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Announces Chairman Transition
|
|
awildana
|
14 |
3.5K |
0 |
01/07/23 |
01/07/23 |
ASX - By Stock
|
14
|
3.5K
|
0
|
|
ASX - By Stock
|
IMC |
Juvia
|
|
awildana
|
1 |
836 |
1 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
1
|
836
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Q3 FY23 Business Update Presentation
|
|
awildana
|
22 |
8.1K |
1 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
22
|
8.1K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Q3 FY23 Business Update Presentation
|
|
awildana
|
22 |
8.1K |
2 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
22
|
8.1K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic
|
|
awildana
|
51 |
13K |
2 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
51
|
13K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic
|
|
awildana
|
51 |
13K |
1 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
51
|
13K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic
|
|
awildana
|
51 |
13K |
1 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
51
|
13K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Q3 FY23 Business Update Presentation
|
|
awildana
|
22 |
8.1K |
1 |
29/04/23 |
29/04/23 |
ASX - By Stock
|
22
|
8.1K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Q3 FY23 Business Update Presentation
|
|
awildana
|
22 |
8.1K |
0 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
22
|
8.1K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Protectyn Potential???
|
|
awildana
|
7 |
1.9K |
1 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
7
|
1.9K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Protectyn Potential???
|
|
awildana
|
7 |
1.9K |
0 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
7
|
1.9K
|
0
|
|